Lumida
/ZUMZ
⌘K
Zumiez Inc

Zumiez Inc

ZUMZ
$18.69USD-0.95%-0.18 today

MARKET CAP

315.3M

P/E (TTM)

22.5x

FWD P/E

18.1x

DAY RANGE

$19 – $19

52W RANGE

$13
$32

AI Summary

Stalk
TrimMedium

ZUMZ is in a Stage 4 decline with a bearish medium-term bias supported by downtrending EMAs and a sequence of lower highs and lows. Short-term timing is neutral as price consolidates below the declining 9EMA and 21EMA, offering no clear entry for a new sell. We will defer bearish execution, looking to trim into rallies into the 9EMA/21EMA resistance zone while awaiting confirmation of downside continuation.

  • Q3 2025 comparable sales rose 7.6% YoY, driven by North America.
  • Private label penetration reached 34% in Q1 2026, lifting gross margins.
  • Europe comps declined 7.5% YoY, exposing international market risks.
Full analysis →

The case for & against

Bull & Bear analysis

Bearish

Zumiez Inc. (NASDAQ: ZUMZ) operates in the specialty retail sector, primarily focusing on action sports-inspired apparel, footwear, and accessories. The company has established a strong brand presence in North America but is facing challenges in international markets, particularly in Europe. With strategic initiatives aimed at expanding its private label offerings and enhancing customer engagement, Zumiez is positioned to capitalize on evolving consumer preferences while navigating a complex retail landscape amid macroeconomic pressures.

Bull says

  • Q3 2025 comparable sales rose 7.6% YoY, driven by North America.
  • Private label penetration reached 34% in Q1 2026, lifting gross margins.
  • $25.2M buybacks in Q1 2025 alongside a $124M cash reserve.
  • Gross margin improved to 31.7% from 30% year-over-year.
  • Strong book-to-price ratio and high earnings yield underpin valuation.
  • Positive momentum and strong balance sheet health support stock strength.

Bear says

  • Europe comps declined 7.5% YoY, exposing international market risks.
  • Management projects negative sales growth amid evolving macro pressures.
  • Store closures of 26 locations could cut about $14M in sales.
  • Litigation settlement costs increased SG&A, straining profit margins.
  • High stock volatility may deter risk-averse investors.
  • No dividend yield and small scale limit shareholder returns.

Investment themes with ZUMZ

Buybacks +0.48%

Companies repurchasing their own shares

C · JCI · WFC

Earnings Call · Q1 2025 · Mgmt. Guidance

Updated 07-08-2026neutral

Transcript signals

Bull points

  • I'm pleased to report that our first quarter results demonstrate the continued momentum we built throughout 2024 with our North American business proving resilient despite an increasingly complex macroeconomic backdrop.
  • Comparable sales for the company grew 5.5%, marking our fourth consecutive quarter of positive comparable sales growth. This performance reflects the successful execution of our strategic initiatives and our team's ability to adapt quickly to changing market conditions.
  • What's particularly encouraging is that our results exceed the high end of our guidance ranges for both sales and profitability, excluding a one-time legal settlement that Chris will touch on later.

Bear points

  • the market environment remains challenging. After making progress in 2024 in sales, product margin, and operating results, 2025 is off to a tougher start.
  • our other international comparable sales turned negative in the first quarter, and we're down 2.3%.
  • inclusive of the previously mentioned one-time legal settlement worth $2.9 million or 13 cents per share. This compares to a net loss of $16.8 million or 86 cents per share for the first quarter of 2024.
Read full transcript analysis ›